TABLE OF CONTENTS
Volume 15, Issue 2 (February 2008)
Original Articles
Anticancer activity of oncolytic adenovirus vector armed with IFN-
and ADP is enhanced by pharmacologically controlled expression of TRAIL
E V Shashkova, M N Kuppuswamy, W S M Wold and K Doronin
Cancer Gene Ther 15: 61-72; advance online publication, November 9, 2007; doi:10.1038/sj.cgt.7701107
Treatment of pulmonary metastatic tumors in mice using lentiviral vector-engineered stem cells
X Zhang, P Zhao, C Kennedy, K Chen, J Wiegand, G Washington, L Marrero and Y Cui
Cancer Gene Ther 15: 73-84; advance online publication, December 14, 2007; doi:10.1038/sj.cgt.7701108
Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B
J Fensterle, B Bergmann, C L R P Yone, C Hotz, S R Meyer, S Spreng, W Goebel, U R Rapp and I Gentschev
Cancer Gene Ther 15: 85-93; advance online publication, December 14, 2007; doi:10.1038/sj.cgt.7701109
Tumor targeting carboxylesterase fused with anti-CEA scFv improve the anticancer effect with a less toxic dose of irinotecan
J Uchino, K Takayama, A Harada, T Sone, T Harada, D T Curiel, M Kuroki and Y Nakanishi
Cancer Gene Ther 15: 94-100; advance online publication, December 21, 2007; doi:10.1038/sj.cgt.7701100
Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma
Y Shi, M Zou, E Y Baitei, A S Alzahrani, R S Parhar, Z Al-Makhalafi and F A Al-Mohanna
Cancer Gene Ther 15: 101-107; advance online publication, December 21, 2007; doi:10.1038/sj.cgt.7701101
DNA immunization using constant-current electroporation affords long-term protection from autochthonous mammary carcinomas in cancer-prone transgenic mice
C Curcio, A S Khan, A Amici, M Spadaro, E Quaglino, F Cavallo, G Forni and R Draghia-Akli
Cancer Gene Ther 15: 108-114; advance online publication, November 9, 2007; doi:10.1038/sj.cgt.7701106
Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase gene
S Chalikonda, M H Kivlen, M E O'Malley, X D (Eric) Dong, J A McCart, M C Gorry, X-Y Yin, C K Brown, H J Zeh III, Z S Guo and D L Bartlett
Cancer Gene Ther 15: 115-125; advance online publication, December 14, 2007; doi:10.1038/sj.cgt.7701110
